Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema

NCT00576459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: 0.59 mg fluocinolone acetonide intravitreal implant
DRUG: 2.1 mg fluocinolone acetonide intravitreal implant
PROCEDURE: standard of care laser photocoagulation

Sponsor

Bausch & Lomb Incorporated